Biotricity, Inc. (BTCY)
USD 0.35
(0.0%)
USD 0.35
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 35.91 Million USD | 36.29% |
| 2023 | 26.35 Million USD | 40.02% |
| 2022 | 18.82 Million USD | 67.0% |
| 2021 | 11.27 Million USD | 125.21% |
| 2020 | 5 Million USD | 120.64% |
| 2019 | 2.26 Million USD | 199.97% |
| 2018 | 756.17 Thousand USD | -84.44% |
| 2017 | 4.85 Million USD | 176.31% |
| 2016 | 1.75 Million USD | 570.27% |
| 2015 | 262.32 Thousand USD | 53.8% |
| 2014 | 170.56 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 35.91 Million USD | 11.5% |
| 2024 Q1 | 29.55 Million USD | 12.14% |
| 2024 FY | 35.91 Million USD | 36.29% |
| 2024 Q3 | 32.21 Million USD | -0.25% |
| 2024 Q2 | 32.29 Million USD | 9.27% |
| 2023 Q2 | 18.67 Million USD | -0.18% |
| 2023 FY | 26.35 Million USD | 40.02% |
| 2023 Q4 | 26.35 Million USD | 19.1% |
| 2023 Q3 | 22.12 Million USD | 18.48% |
| 2023 Q1 | 18.71 Million USD | -0.6% |
| 2022 Q4 | 18.82 Million USD | 0.51% |
| 2022 FY | 18.82 Million USD | 67.0% |
| 2022 Q3 | 18.72 Million USD | 201.69% |
| 2022 Q2 | 6.2 Million USD | -53.56% |
| 2022 Q1 | 13.36 Million USD | 18.59% |
| 2021 FY | 11.27 Million USD | 125.21% |
| 2021 Q1 | 6.37 Million USD | 27.36% |
| 2021 Q3 | 15.84 Million USD | 67.15% |
| 2021 Q4 | 11.27 Million USD | -28.88% |
| 2021 Q2 | 9.48 Million USD | 48.73% |
| 2020 Q3 | 7.44 Million USD | 24.95% |
| 2020 Q1 | 4.31 Million USD | 90.11% |
| 2020 Q4 | 5 Million USD | -32.75% |
| 2020 FY | 5 Million USD | 120.64% |
| 2020 Q2 | 5.95 Million USD | 38.11% |
| 2019 FY | 2.26 Million USD | 199.97% |
| 2019 Q2 | 1.04 Million USD | 4.12% |
| 2019 Q1 | 1 Million USD | 33.1% |
| 2019 Q4 | 2.26 Million USD | 71.35% |
| 2019 Q3 | 1.32 Million USD | 26.33% |
| 2018 Q2 | 762.8 Thousand USD | -84.05% |
| 2018 FY | 756.17 Thousand USD | -84.44% |
| 2018 Q4 | 756.17 Thousand USD | 20.01% |
| 2018 Q3 | 630.08 Thousand USD | -17.4% |
| 2018 Q1 | 4.78 Million USD | -1.58% |
| 2017 FY | 4.85 Million USD | 176.31% |
| 2017 Q1 | 3.77 Million USD | 38.46% |
| 2017 Q2 | 2.59 Million USD | -31.27% |
| 2017 Q3 | 4.13 Million USD | 59.24% |
| 2017 Q4 | 4.85 Million USD | 17.46% |
| 2016 Q1 | 262.18 Thousand USD | 0.0% |
| 2016 Q2 | 262.32 Thousand USD | 0.05% |
| 2016 Q3 | 1.75 Million USD | 570.27% |
| 2016 Q4 | 2.72 Million USD | 55.24% |
| 2016 FY | 1.75 Million USD | 570.27% |
| 2015 FY | 262.32 Thousand USD | 53.8% |
| 2015 Q2 | 170.56 Thousand USD | 0.0% |
| 2014 FY | 170.56 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 29.919% |
| BrainsWay Ltd. | 15.31 Million USD | -134.553% |
| Cerus Corporation | 144.3 Million USD | 75.108% |
| Envoy Medical, Inc. | 9.4 Million USD | -282.04% |
| electroCore, Inc. | 8.94 Million USD | -301.559% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -572.397% |
| IceCure Medical Ltd | 4.24 Million USD | -745.76% |
| Inogen, Inc. | 121.38 Million USD | 70.408% |
| OrthoPediatrics Corp. | 72.56 Million USD | 50.498% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -21.427% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -1028.852% |
| MaxCyte, Inc. | 36.1 Million USD | 0.519% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -1843.787% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -8346.049% |
| Orthofix Medical Inc. | 326.58 Million USD | 89.002% |
| PAVmed Inc | 57.13 Million USD | 37.135% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -41.065% |
| RxSight, Inc. | 22.18 Million USD | -61.887% |
| Sight Sciences, Inc. | 46.43 Million USD | 22.647% |
| SI-BONE, Inc. | 61.05 Million USD | 41.164% |
| TELA Bio, Inc. | 59.16 Million USD | 39.291% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 68.483% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -248.09% |
| Acutus Medical, Inc. | 54.83 Million USD | 34.5% |
| Talis Biomedical Corporation | 29.22 Million USD | -22.911% |
| Spectral AI, Inc. | 12.4 Million USD | -189.65% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -55.267% |
| CVRx, Inc. | 39.28 Million USD | 8.56% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -200.378% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -1378.592% |
| Bioventus Inc. | 589.79 Million USD | 93.91% |
| Venus Concept Inc. | 107.1 Million USD | 66.463% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 30.474% |
| LivaNova PLC | 1.15 Billion USD | 96.882% |
| 908 Devices Inc. | 37.49 Million USD | 4.189% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 94.894% |
| Nemaura Medical Inc. | 26.37 Million USD | -36.175% |
| NeuroPace, Inc. | 86.99 Million USD | 58.712% |
| LENSAR, Inc. | 22.4 Million USD | -60.29% |
| Apyx Medical Corporation | 52.31 Million USD | 31.344% |
| Cutera, Inc. | 518.12 Million USD | 93.067% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -22.475% |
| BioSig Technologies, Inc. | 4.68 Million USD | -666.69% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 38.459% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -67.16% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 98.363% |
| Axonics, Inc. | 82.35 Million USD | 56.387% |
| Outset Medical, Inc. | 190.91 Million USD | 81.186% |
| IRIDEX Corporation | 24.91 Million USD | -44.174% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 71.025% |
| IRadimed Corporation | 20.73 Million USD | -73.223% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -2045.725% |
| INVO Bioscience, Inc. | 19.99 Million USD | -79.642% |
| Telesis Bio, Inc. | 40.87 Million USD | 12.119% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 11.941% |
| Varex Imaging Corporation | 668.6 Million USD | 94.628% |
| Quipt Home Medical Corp. | 136.29 Million USD | 73.645% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -905.583% |
| Pulmonx Corporation | 60.63 Million USD | 40.762% |
| Dynatronics Corporation | 11.78 Million USD | -204.916% |
| Modular Medical, Inc. | 2.27 Million USD | -1480.961% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -783.845% |
| Semler Scientific, Inc. | 6.27 Million USD | -472.878% |
| InMode Ltd. | 75.91 Million USD | 52.684% |
| Bruker Corporation | 2.83 Billion USD | 98.734% |
| Cytosorbents Corporation | 29.98 Million USD | -19.789% |
| DexCom, Inc. | 4.19 Billion USD | 99.144% |
| Align Technology, Inc. | 2.45 Billion USD | 98.536% |
| Viveve Medical, Inc. | 10.84 Million USD | -231.146% |
| ZimVie Inc. | 795.85 Million USD | 95.487% |
| Movano Inc. | 5.97 Million USD | -501.464% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 65.662% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -8346.049% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -200.378% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 94.379% |
| Profound Medical Corp. | 12.66 Million USD | -183.593% |
| Insulet Corporation | 1.85 Billion USD | 98.064% |
| enVVeno Medical Corporation | 2.43 Million USD | -1375.131% |
| Surmodics, Inc. | 65.82 Million USD | 45.43% |
| iCAD, Inc. | 8 Million USD | -348.937% |
| Nuwellis, Inc. | 6.78 Million USD | -429.785% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 83.896% |
| Aethlon Medical, Inc. | 2.47 Million USD | -1348.569% |
| InspireMD, Inc. | 8.14 Million USD | -341.162% |
| PAVmed Inc. | 57.13 Million USD | 37.135% |
| BIOLASE, Inc. | 35.34 Million USD | -1.617% |
| Beyond Air, Inc. | 29.77 Million USD | -20.636% |
| FONAR Corporation | 57.45 Million USD | 37.485% |
| AxoGen, Inc. | 101.16 Million USD | 64.493% |
| Vivani Medical, Inc. | 25.03 Million USD | -43.471% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 59.088% |
| Inari Medical, Inc. | 209.32 Million USD | 82.84% |
| UFP Technologies, Inc. | 118.04 Million USD | 69.571% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -183.042% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -1543.3% |
| Tenon Medical, Inc. | 5.56 Million USD | -545.221% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -1919.08% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -103.693% |
| AdaptHealth Corp. | 3.15 Billion USD | 98.861% |
| Sintx Technologies, Inc. | 6.59 Million USD | -444.812% |
| NanoVibronix, Inc. | 2.68 Million USD | -1237.284% |
| Quanterix Corporation | 78.08 Million USD | 53.999% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -905.583% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -635.301% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 96.562% |
| TransMedics Group, Inc. | 568.84 Million USD | 93.686% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -115.319% |
| NeuroMetrix, Inc. | 1.33 Million USD | -2594.381% |
| Hyperfine, Inc. | 9.8 Million USD | -266.525% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 85.646% |
| Biomerica, Inc. | 2.66 Million USD | -1248.834% |
| Bone Biologics Corporation | 831.4 Thousand USD | -4220.346% |
| AVITA Medical, Inc. | 19.86 Million USD | -80.814% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -1719.92% |
| Silk Road Medical, Inc | 114.15 Million USD | 68.535% |